Fiji Northern Division Ivermectin Mass Drug Administration for Scabies Trial

Phase 3

Completed

• Conditions: Public Health - Other public health; Scabies; Impetigo; Skin and soft tissue infections; Invasive group A streptococcal infections; Invasive Staphylococcus aureus infection; Post streptococcal glomerulonephritis; Acute rheumatic fever; Rheumatic heart disease; Bacteraemia

• Registration Number: ACTRN12618000461291
• Lead Sponsor: Murdoch Children's Research Insititute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-29
• Study Completion: 2020-07-31
• Last Update Posted: 21 July 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 139977

Inclusion Criteria

All consenting residents of the Northern Division are eligible to be included in the study

Exclusion Criteria

No treatment will be given to patients who are seriously ill: inpatients in hospital and bedridden in the community.

Study & Design

• Study Type: Interventional
• Study Design: Not specified